Monoclonal antibody A7-zinostatin conjugate

Drug Profile

Monoclonal antibody A7-zinostatin conjugate

Alternative Names: A7-NCS; Monoclonal antibody A7-neocarzinostatin conjugate

Latest Information Update: 17 Aug 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Cytostatic antibiotics; Drug conjugates; Enediynes; Immunoconjugates; Monoclonal antibodies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Colorectal cancer; Pancreatic cancer

Most Recent Events

  • 17 Aug 2001 No-Development-Reported for Colorectal cancer in Japan (IV)
  • 17 Aug 2001 No-Development-Reported for Pancreatic cancer in Japan (IV)
  • 23 Jan 1997 Investigation in Colorectal cancer in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top